Sun Pharmaceuticals Industries announced that the wholly owned subsidiary of the company has increased its shareholding in PJSC Biosintez, Russia, by way of purchase of 8698 shares (2391 ordinary shares and 6307 preferred shares) equivalent to 3.04% ofPJSC Biosintez under Mandatory Tender Offer.
Post completion of this purchase of shares, the total holding of wholly owned subsidiary company was increased from 96.96% to 100% in PJSC Biosintez.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
